Recombinant humanized anti-VEGF monoclonal antibody (Bio-Thera Solutions)

维拉西塔单抗

Report date: 2026/04/08 20:02:35

Base Information

Drug NameRecombinant humanized anti-VEGF monoclonal antibody (Bio-Thera Solutions)
Drug Alias Name重组抗VEGF人源化单克隆抗体注射液（百奥泰生物）重组抗VEGF人源化单克隆抗体（百奥泰生物）BAT-5906
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionVascular endothelial growth factor inhibitors
TargetsVascular endothelial growth factor
Therapy Area/IndicationsDiabetic macular oedemaChoroidal NeovascularizationWet age-related macular degeneration +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusNDA/BLA
Highest Status in ChinaNDA/BLA
Originator CompaniesBio-Thera Solutions Ltd
China Registration ClassClass 1 therapeutic biologic in China

Develop Information

Active CompaniesBio-Thera Solutions Ltd
Inactive CompaniesN/A
Active IndicationsDiabetic macular oedemaChoroidal NeovascularizationWet age-related macular degeneration +[5] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A